{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:03:42Z","timestamp":1774616622714,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024017","name":"Sheba Medical Center","doi-asserted-by":"publisher","award":["3113-16-SMC"],"award-info":[{"award-number":["3113-16-SMC"]}],"id":[{"id":"10.13039\/501100024017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.amjmed.2023.11.018","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T19:58:22Z","timestamp":1701374302000},"page":"266-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Medication-Related Osteonecrosis of the Jaw: A Cross-Sectional Study on the Prevalence of Cutaneous Manifestations and the Primary Care Physician's Role in its Early Diagnosis"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-8103","authenticated-orcid":false,"given":"Sara","family":"Whitefield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mor Bar","family":"Ilan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Towy Sorel","family":"Lazarovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvina","family":"Friedlander-Barenboim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riad","family":"Kassem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noam","family":"Yarom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjmed.2023.11.018_bib0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/1759720X10387202","article-title":"Cutaneous side effects of antiosteoporosis treatments","volume":"3","author":"Musette","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"12","key":"10.1016\/j.amjmed.2023.11.018_bib0002","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s00198-021-06021-2","article-title":"Diffuse adverse cutaneous reactions induced by zoledronic acid administration: a case report: eruptions cutan\u00e9es diffuses induites par l'administration de l'acide zol\u00e9dronique","volume":"32","author":"Nassar","year":"2021","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.amjmed.2023.11.018_bib0003","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/DAD.0000000000000341","article-title":"Zoledronic acid-induced interface dermatitis","volume":"37","author":"Succaria","year":"2015","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.amjmed.2023.11.018_bib0004","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.jaad.2009.04.015","article-title":"Zoledronic acid-induced cutaneous B-cell pseudolymphoma","volume":"65","author":"Kitagawa","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjmed.2023.11.018_bib0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.oraloncology.2009.10.004","article-title":"Osteonecrosis of the jaws induced by drugs other than bisphosphonates \u2013 a call to update terminology in light of new data","volume":"46","author":"Yarom","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.amjmed.2023.11.018_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8071579","article-title":"Osteonecrosis of the jaw associated with Antiangiogenics in antiresorptive-na\u00efve patient: a comprehensive review of the literature","author":"Pimolbutr","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.amjmed.2023.11.018_bib0007","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jdcr.2021.12.007","article-title":"Skin involvement of medication-related osteonecrosis of jaws in an immunocompromised, bisphosphonate-treated patient","volume":"20","author":"Kim","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"6","key":"10.1016\/j.amjmed.2023.11.018_bib0008","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2230.2010.04008.x","article-title":"Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw","volume":"36","author":"Kang","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.amjmed.2023.11.018_bib0009","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jaad.2008.09.021","article-title":"Bisphosphonate-related osteonecrosis of the jaw presenting as a cutaneous dental sinus tract: a case report and review of the literature","volume":"62","author":"Truong","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.amjmed.2023.11.018_bib0010","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.amjmed.2023.11.018_bib0011","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00774-020-01113-1","article-title":"Changing face of medication-related osteonecrosis of the jaw: Sheba Medical Center experience-fifteen years","volume":"38","author":"Whitefield","year":"2020","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"10.1016\/j.amjmed.2023.11.018_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.oooo.2017.09.014","article-title":"Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab","volume":"125","author":"Yarom","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"10.1016\/j.amjmed.2023.11.018_bib0013","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1517\/17425255.2015.1000860","article-title":"Denosumab for the treatment of osteoporosis","volume":"11","author":"Zaheer","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.amjmed.2023.11.018_bib0014","first-page":"447","article-title":"Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer","volume":"24","author":"Stopeck","year":"2016","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.1016\/j.amjmed.2023.11.018_bib0015","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.amjmed.2023.11.018_bib0016","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.amjmed.2023.11.018_bib0017","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"25","key":"10.1016\/j.amjmed.2023.11.018_bib0018","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.amjmed.2023.11.018_bib0019","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.amjmed.2023.11.018_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/dj10050089","article-title":"Medication-related osteonecrosis of the jaw in dental practice: a retrospective analysis of data from the Milan cohort","volume":"10","author":"Mirelli","year":"2022","journal-title":"Dent J (Basel)"},{"issue":"2","key":"10.1016\/j.amjmed.2023.11.018_bib0021","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fon.13.211","article-title":"Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw osteonecrosis in cancer patients exposed to antiresorptive agents","volume":"10","author":"Campisi","year":"2014","journal-title":"Future Oncol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323007416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934323007416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:30:22Z","timestamp":1757583022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934323007416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0002934323007416"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.11.018","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-Related Osteonecrosis of the Jaw: A Cross-Sectional Study on the Prevalence of Cutaneous Manifestations and the Primary Care Physician's Role in its Early Diagnosis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2023.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}